The announcement of a mixed shelf offering typically leads to a short-term negative impact on a company's stock price due to potential dilution of existing shares. Given the size of the offering relative to Jaguar Health's market cap, this news is likely to have a significant negative impact on investor sentiment and the stock's price in the short term.